|
Volumn 26, Issue , 1996, Pages 149-157
|
Clinical development plan: phenethyl isothiocyanate.
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ISOTHIOCYANIC ACID DERIVATIVE;
PHENETHYL ISOTHIOCYANATE;
ANIMAL;
ARTICLE;
DOG;
DRUG APPROVAL;
EXPERIMENTAL NEOPLASM;
HUMAN;
LUNG TUMOR;
METHODOLOGY;
MOUSE;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
RAT;
ANIMALS;
ANTICARCINOGENIC AGENTS;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
DOGS;
DRUG APPROVAL;
HUMANS;
ISOTHIOCYANATES;
LUNG NEOPLASMS;
MICE;
NEOPLASMS, EXPERIMENTAL;
RATS;
RESEARCH DESIGN;
|
EID: 0030320687
PISSN: 07331959
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (24)
|
References (0)
|